# FDA Inspection 1192827 - CSL Plasma Inc. - December 08, 2022

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/d22abbcb-b7ea-4665-96a4-c12c667d089b
Source feed: FDA_Inspections

> FDA Inspection 1192827 for CSL Plasma Inc. on December 08, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192827
- Company Name: CSL Plasma Inc.
- Inspection Date: 2022-12-08
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1192827 - 2022-12-08](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/c5d91776-2c9f-40c0-8f53-63df63ac8cf7)
- [FDA Inspection 1018475 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/154649f4-ae0e-46fd-b1b4-1a58cacff4fd)
- [FDA Inspection 836476 - 2013-05-31](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/c891091b-6dc5-427b-8efe-84d7bf77649f)

Company: https://www.keypedia.com/companies/csl-plasma-inc/51ca7fc9-8303-4dd8-8c3e-1843236f5a05

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d